Medovex Corporation Enters Into Master Manufacturing, Development and Service Agreement With ComDel Innovation, Inc.
ATLANTA, GA--(Marketwired - July 22, 2015) - Medovex Corp. (NASDAQ: MDVX), a developer of medical technology products, today announced that it has entered into a Master Manufacturing, Development and Service Agreement with ComDel Innovation, Inc., of Wahpeton, ND.
ComDel is a leading developer and manufacturer of medical devices and has an FDA certified ISO 13485 facility. Jarrett Gorlin, CEO, said, "The agreement is expected to provide for continued development and manufacturing of the Streamline® IV Suspension System product, as well as assisting in the development of future product line extensions in the safe patient treatment space."
According to Patrick Kullmann, President and COO, "ComDel is uniquely positioned and qualified to provide quality development and manufacturing support as Medovex™ continues to manage and maximize production and cost strategies seeking to further enhance the profitability profile of the Streamline IV Suspension System, along with future expansion products under development."
Streamline developed the IV Suspension System (ISS), a patient equipment management device that makes the transport of patients and their equipment within hospitals safe and efficient.
The ISS system is designed to enable caregivers to easily move and manage IV pump units through its innovative design. Once securely attached to either the stretcher or bed frame, the system's "legs" retract and are safely locked and off the ground to allow easy, hands-free transport of the equipment.
About Medovex
Medovex was formed to acquire and develop a diversified portfolio of potentially ground breaking medical technology products. Criteria for selection include those products with potential for significant improvement in the quality of patient care combined with cost effectiveness. The Company's first pipeline product, the DenerveX device, is intended to provide long lasting relief from pain associated with facet joint syndrome at significantly less cost than currently available options. To learn more about Medovex Corp., visit www.medovex.com
About ComDel Innovation
CDI's customer-first focus backed by our years of experience enables us to meet the rigid manufacturing demands of our customers. Total customer satisfaction is our only measure of success. Our team has a heritage of quality and performance in the technology industry. From the beginning, we've honed our skills in new product development, sharpened our focus on manufacturing excellence, and dedicated ourselves to continuous improvement. To learn more about ComDel, visit www.comdelinc.com
Safe Harbor Statement
Certain statements in this press release constitute "forward-looking statements" within the meaning of the federal securities laws. Words such as "may," "might," "will," "should," "believe," "expect," "anticipate," "estimate," "continue," "predict," "forecast," "project," "plan," "intend" or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. While the Company believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward looking statements are based upon current estimates and assumptions and are subject to various risks and uncertainties, including without limitation those set forth in the Company's filings with the Securities and Exchange Commission (the "SEC"), not limited to Risk Factors relating to its patent business contained therein. Thus, actual results could be materially different. The Company expressly disclaims any obligation to update or alter statements whether as a result of new information, future events or otherwise, except as required by law.